US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

UK contract research organization hVIVO (AIM: HVO) is gearing up to test an inhaled antiviral candidate, IN-002, for ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Confronting a bird flu outbreak in nature presents unique challenges, as infected animals leave a landscape contaminated, Pa.

A 4-year-old boy from Ahmedabad city has contracted human metapneumovirus, taking the number of HMPV cases in Gujarat to ...

We’ve seen lots of claims about human metapneumovirus (hMPV) in recent weeks. This explainer looks at what we know about it.

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

An Ahmedabad boy, aged four, has tested positive for human metapneumovirus, raising Gujarat's total cases to eight. The child ...

A 4-year-old boy in Ahmedabad has been diagnosed with human metapneumovirus, increasing Gujarat's cases to eight. The child is in stable condition. The virus, spreading since 2001, resembles the ...